libj Quest

libj Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name LIPID PANEL, STANDARD CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL Specimen: MR780669K Requisition: 0006001 Collected: Received: Reported: 08/03/2018 08/07/2018 I 08:58 EDT 08/07/2018 I 08:59 EDT Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 In Range Out Of Range Reference Range 244 H <200 mg/dL 29 L >40 mg/dL 855 H <150 mg/dL LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 8.4 H NON HDL CHOLESTEROL 215 H For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 mg/dL (talc) <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 16.1 H Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid however, Lab MI MI MI MI MI MI TP <11.4 umol/L MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGEI0F5 EFTA00317114 rajQuest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY Specimen: MR780669K Client #: 78300020 Collected: 08/03/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/07/2018 I 08:58 EDT Gender: M Reported: 08/07/2018 I 08:59 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC PANEL GLUCOSE 106 H For someone without known diabetes, a glucose value between 100 and 125 mg/dL is consistent with prediabetes and should be confirmed with a follow-up test. UREA NITROGEN (BUN) 22 CREATININE 1.11 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT 69 80 NOT APPLICABLE 142 4.4 103 21 7.4 4.6 2.8 1.6 0.7 61 23 38 10.5 R HEMOGLOBIN Ale 5.7 H For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. Range 65-99 mg/dL Fasting reference interval This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 7.2 7-25 mg/dL 0.70-1.25 mg/dL > OR = 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (calc) 135-146 mmol/L 3.5-5.3 mmoi/L 98-110 mmol/L 20-31 mmol/L 8.6-10.3 mg/dL 6.1-8.1 g/dL 3.6-5.1 g/dL 1.9-3.7 g/dL (calc) 1.0-2.5 (calc) 0.2-1.2 mg/dL 40-115 U/L 10-35 U/L 9-46 U/L <5.7 % of total Hgb 4.0-8.0 mg/dL Lab MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 5 EFTA00317115 Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Clientheonnation EPSTEIN, JEFFREY Specimen: MR780669K Client #: 78300020 Collected: 08/03/2018 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/07/2018 I 08:58 EDT Gender: M Reported: 08/07/2018 I 08:59 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name Therapeutic target In Range for gout patients: <6.0 Out Of Range mg/dL TSH 3.41 T4 (THYROXINE), TOTAL 8.3 FREE T4 INDEX (T7) 2.4 T3 UPTAKE 29 SED RATE BY MODIFIED WESTERGREN 6 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 7.5 RED BLOOD CELL COUNT 5.65 HEMOGLOBIN 16.4 HEMATOCRIT 47.6 MCV 84.2 MCH 29.0 MCHC 34.5 RDW 13.9 PLATELET COUNT 301 MPV 9.6 ABSOLUTE NEUTROPHILS 3420 ABSOLUTE LYMPHOCYTES 2880 ABSOLUTE MONOCYTES 705 ABSOLUTE EOSINOPHILS 435 ABSOLUTE BASOPHILS 60 NEUTROPHILS 45.6 LYMPHOCYTES 38.4 MONOCYTES 9.4 EOSINOPHILS 5.8 BASOPHILS 0.8 URINALYSIS, COMPLETE See Endnote 2 VITAMIN B12 423 C-REACTIVE PROTEIN 1.5 TESTOSTERONE, TOTAL MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 206 L In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. PSA, TOTAL 0.6 The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute Reference Range 0.40-4.50 mIU/L 4.5-12.0 mcg/dL 1.4-3.8 22-35 % < OR= 20 mm/h 3.8-10.8 Thousand/uL 4.20-5.80 Million/uL 13.2-17.1 g/dL 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thousand/uL 7.5-12.5 fL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL 200-1100 pg/mL <8.0 mg/L 250-827 ng/dL < OR = 4.0 ng/mL Lab MI MI MI MI MI MI MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F5 EFTA00317116 rajQuest Diagnostics' —.0 Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: Collected: Received: Reported: MR780669K 08/03/2018 08/07/2018 / 08:58 EDT 08/07/2018 / 08:59 EDT Test Name In Range Out Of Range evidence of the presence or absence of disease. Endnote I * Test not performed. * No specimen received. Client Information Client #: 78300020 MOSKOWITZ. BRUCE W Reference Range Lab CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 4 OF 5 EFTA00317117 rajQuest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR780669K Collected: 08/03/2018 Received: 08/07/2018 / 08:58 EDT Reported: 08/07/2018 / 08:59 EDT Client #: 78300020 MOSKOWITZ, BRUCE W Endocrinology Test Name VITAMIN D,25.OH,TOTAL,IA Vitamin D Status Result Reference Range 32 30-100 ng/mL Lab MI Deficiency: Insufficiency: Optimal: For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). 25-OH Vitamin D: <20 ng/mL 20 - 29 ng/mL > or = 30 ng/mL For more information on this test, go to: (This link is being provided for informational/ educational purposes only.) Physician Comments: PERFORMING SITE: MI QUEST DIAGNOSTICS.NIIAMI. 10330 COMMERCE PARKWAY. MIRAMAR. FL 33015-3915 Laboratory DUCCIOI: GLEN L. IIORTIN MD PHD. CLIA 1 000277334 TP QUEST D1AGNOSTICSTAMPA. 1225 E FOWLER AVE TAMPA. FL 33617.2026 Laboratory Dire,: tor GLEN L HORTIN.MD.FIID. CLIA 1000291120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00317118